Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Revive Therapeutics Ltd
Bullboard Posts
User Avatar Image
(149)
•••
Post by GarlicToaston Aug 15, 2020 11:08pm
307 Views
Post# 31413832

Latest 10 SEDI filings for RVV within the last 6 months

Latest 10 SEDI filings for RVV within the last 6 monthsWhen Insider is buying then it’s time to get onboard. 

Insider Filings

Latest 10 SEDI filings for RVV within the last 6 months
 Amended Filing
As of 11:59pm ET August 15th, 2020

Filing
Date		 Transaction
Date		 Insider Name Ownership
Type		 Securities Nature of transaction Volume or Value Price
Aug 10/20 Aug 5/20 Frank, Michael Direct Ownership Options 50 - Grant of options 6,000,000 $0.330
May 25/20 May 25/20 Marrelli, Carmelo Direct Ownership Options 50 - Grant of options 500,000  
May 25/20 May 25/20 Frank, Michael Direct Ownership Options 50 - Grant of options 3,000,000  
Apr 22/20 Apr 15/20 Scovenna, Christian Direct Ownership Warrants 16 - Acquisition under a prospectus exemption 1,500,000  
Apr 22/20 Apr 15/20 Scovenna, Christian Direct Ownership Common Shares 16 - Acquisition under a prospectus exemption 1,500,000 $0.050
Mar 19/20 Mar 18/20 Scovenna, Christian Direct Ownership Warrants 16 - Acquisition under a prospectus exemption 500,000  
Mar 19/20 Mar 18/20 Scovenna, Christian Direct Ownership Common Shares 16 - Acquisition under a prospectus exemption 500,000 $0.050
May 26/20 Mar 5/20 Welsh, Derrick Alexander Direct Ownership Common Shares 00 - Opening Balance-Initial SEDI Report 2,000,000

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities